Providing robust EU funding for cancer research is a key requisite for driving the development of innovative cancer treatments, meeting the unmet needs of patients with cancer, and supporting the work of medical oncologists in Europe and beyond
Providing robust EU funding for cancer research is a key requisite for driving the development of innovative cancer treatments, meeting the unmet needs of patients with cancer, and supporting the work of medical oncologists in Europe and beyond